Holen Sie sich die Stockscreener-App
2.4792
1.70%
0.1192
Schlusskurs vom Vortag:
$2.36
Offen:
$2.4
24-Stunden-Volumen:
164.43K
Relative Volume:
1.41
Marktkapitalisierung:
$7.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.24M
KGV:
-0.4439
EPS:
-5.5853
Netto-Cashflow:
$-8.09M
1W Leistung:
+2.57%
1M Leistung:
+1.70%
6M Leistung:
-59.87%
1J Leistung:
-83.33%
1-Tages-Spanne:
$2.30
$2.53
1-Wochen-Bereich:
$2.28
$2.5562
52-Wochen-Spanne:
$2.06
$15.21
Alzamend Neuro Inc Stock (ALZN) Company Profile
Firmenname
Alzamend Neuro Inc
Sektor
Branche
Telefon
844-722-6333
Adresse
3500 LENOX RD. NE, ATLANTA
Vergleichen Sie ALZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.4792 | 8.97M | 0 | -6.24M | -8.09M | -5.5853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.66 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.09 | 69.37B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.67 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
823.72 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.71 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-01 | Eingeleitet | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Aktie (ALZN) Neueste Nachrichten
Can Alzamend Neuro Inc. stock outperform in 2025 bull marketJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Will Alzamend Neuro Inc. stock go up soonMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Will Alzamend Neuro Inc. stock pay special dividendsMarket Risk Analysis & Consistent Profit Trading Strategies - newser.com
Multi asset correlation models including Alzamend Neuro Inc.July 2025 Opening Moves & Daily Momentum Trading Reports - newser.com
Will Alzamend Neuro Inc. stock reach all time highs in 20252025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
Is Alzamend Neuro Inc. stock supported by innovation pipeline2025 Stock Rankings & Consistent Profit Alerts - newser.com
Comparing Alzamend Neuro Inc. in custom built stock radars2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Predicting Alzamend Neuro Inc. trend using moving averagesQuarterly Trade Review & Accurate Technical Buy Alerts - newser.com
Alzamend Neuro Inc. stock trend outlook and recovery path2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Is Alzamend Neuro Inc. stock cheap compared to fundamentalsMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
How currency fluctuations impact Alzamend Neuro Inc. stockTrend Reversal & Reliable Trade Execution Plans - newser.com
Will Alzamend Neuro Inc. stock outperform growth indexesEarnings Recap Report & AI Enhanced Trading Signals - Fundação Cultural do Pará
Why Alzamend Neuro Inc. stock could rally in 2025Market Risk Summary & Community Supported Trade Ideas - Fundação Cultural do Pará
Will Alzamend Neuro Inc. stock remain a Wall Street favoriteTrade Volume Summary & High Conviction Investment Ideas - Fundação Cultural do Pará
What earnings revisions data tells us about Alzamend Neuro Inc.2025 Market Overview & Technical Pattern Based Signals - newser.com
Is Alzamend Neuro Inc. stock recession proofEarnings Risk Summary & Community Consensus Picks - newser.com
Will Alzamend Neuro Inc. stock rally after Fed decisionsJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
Historical volatility pattern of Alzamend Neuro Inc. visualizedEarnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com
Why Alzamend Neuro Inc. stock attracts high net worth investorsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Is Alzamend Neuro Inc. forming a bottoming base2025 Geopolitical Influence & Smart Money Movement Tracker - newser.com
Can Alzamend Neuro Inc. stock resist sector downturnsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
What to do if you’re stuck in Alzamend Neuro Inc.Entry Point & Low Risk Entry Point Tips - newser.com
Chart based exit strategy for Alzamend Neuro Inc.Weekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alzamend Neuro Inc-Aktie (ALZN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| AULT MILTON C III | Director |
Oct 08 '25 |
Sale |
2.44 |
101,394 |
247,158 |
28,657 |
| AULT MILTON C III | Director |
Oct 09 '25 |
Sale |
2.32 |
20,397 |
47,390 |
8,260 |
| AULT MILTON C III | Director |
Oct 06 '25 |
Sale |
2.45 |
82,033 |
201,268 |
26,227 |
| AULT MILTON C III | Director |
Oct 07 '25 |
Sale |
2.49 |
57,379 |
142,954 |
68,848 |
| AULT MILTON C III | Director |
Oct 03 '25 |
Sale |
2.44 |
65,903 |
160,889 |
8,260 |
| AULT MILTON C III | Director |
Oct 01 '25 |
Sale |
2.35 |
36,777 |
86,378 |
94,849 |
| AULT MILTON C III | Director |
Oct 02 '25 |
Sale |
2.39 |
20,686 |
49,522 |
74,163 |
| AULT MILTON C III | Director |
Sep 29 '25 |
Sale |
2.31 |
38,324 |
88,490 |
35,192 |
| AULT MILTON C III | Director |
Sep 26 '25 |
Sale |
2.31 |
37,738 |
87,345 |
73,516 |
| AULT MILTON C III | Director |
Sep 30 '25 |
Sale |
2.33 |
3,566 |
8,321 |
31,626 |
0.38%
2.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):